Literature DB >> 9349237

Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis.

K K Krishnadath1, H W Tilanus, M van Blankenstein, W C Hop, E D Kremers, W N Dinjens, F T Bosman.   

Abstract

The E-cadherin-catenin complex is important for cell-cell adhesion of epithelial cells. Impairment of one or more components of this complex is associated with poor differentiation and increased invasiveness of carcinomas. Oesophageal adenocarcinomas causes early metastases, progress rapidly, and consequently have a poor prognosis. By means of immunohistochemistry, the expression of E-cadherin and alpha- and beta-catenin was studied in 65 oesophageal adenocarcinomas and 15 lymph node metastases. Expression of these proteins was evaluated with respect to clinico-pathological parameters and patient survival. Expression of the proteins was strongly correlated. In carcinomas, reduced expression of E-cadherin, alpha-catenin, and beta-catenin was found in 74, 60, and 72 per cent, respectively. Expression of E-cadherin and alpha-catenin correlated significantly with stage and grade of the carcinomas, whereas expression of beta-catenin correlated only with grade. Reduced expression of all three proteins correlated with shorter patient survival. In contrast to grade, E-cadherin and beta-catenin were significant prognosticators for survival, independent of disease stage. We conclude that in oesophageal adenocarcinomas, decreased expression of E-cadherin, alpha-catenin and beta-catenin are related events. Furthermore, expression of at least E-cadherin and beta-catenin is significantly correlated with poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349237     DOI: 10.1002/(SICI)1096-9896(199707)182:3<331::AID-PATH860>3.0.CO;2-D

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  45 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 2.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

3.  Association of Wnt1/beta-catenin with clinical pathological characteristics and prognosis of esophageal squamous cell carcinoma.

Authors:  Jin Lv; Xiu-Feng Cao; Lv Ji; Bin Zhu; Lei Tao; Dong-dong Wang
Journal:  Genet Test Mol Biomarkers       Date:  2010-06

4.  Prognostic relevance of β-catenin expression in T2-3N0M0 esophageal squamous cell carcinoma.

Authors:  Dong-Rong Situ; Yi Hu; Zhi-Hua Zhu; Jian Wang; Hao Long; Tie-Hua Rong
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

5.  Claudin expression in Barrett's esophagus and adenocarcinoma.

Authors:  Hajnalka Gyõrffy; Agnes Holczbauer; Pál Nagy; Zsuzsa Szabó; Péter Kupcsulik; Csilla Páska; János Papp; Zsuzsa Schaff; András Kiss
Journal:  Virchows Arch       Date:  2005-08-30       Impact factor: 4.064

6.  Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.

Authors:  R T Pirinen; P Hirvikoski; R T Johansson; S Hollmén; V M Kosma
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

7.  E-cadherin expression in transitional cell carcinomas.

Authors:  Eszter Székely; Virág Török; Tamás Székely; Péter Riesz; Imre Romics
Journal:  Pathol Oncol Res       Date:  2006-06-24       Impact factor: 3.201

8.  Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.

Authors:  Xi-Jiang Zhao; Hui Li; Hua Chen; Yan-Xue Liu; Li-Hua Zhang; Su-Xiang Liu; Qing-Lai Feng
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma.

Authors:  Ken Sasaki; Shoji Natsugoe; Sumiya Ishigami; Masataka Matsumoto; Hiroshi Okumura; Tetsuro Setoyama; Yasuto Uchikado; Yoshiaki Kita; Kiyokazu Tamotsu; Akihiko Sakamoto; Tetsuhiro Owaki; Takashi Aikou
Journal:  J Exp Clin Cancer Res       Date:  2009-12-21

10.  The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis.

Authors:  Aparna Suryadevara; Lakshmi P Paruchuri; Nassim Banisaeed; Gary Dunnington; Krishna A Rao
Journal:  World J Surg Oncol       Date:  2010-06-21       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.